238 related articles for article (PubMed ID: 34526912)
1. Optogenetic Stimulation Using Anion Channelrhodopsin (GtACR1) Facilitates Termination of Reentrant Arrhythmias With Low Light Energy Requirements: A Computational Study.
Ochs AR; Karathanos TV; Trayanova NA; Boyle PM
Front Physiol; 2021; 12():718622. PubMed ID: 34526912
[TBL] [Abstract][Full Text] [Related]
2. Opsin spectral sensitivity determines the effectiveness of optogenetic termination of ventricular fibrillation in the human heart: a simulation study.
Karathanos TV; Bayer JD; Wang D; Boyle PM; Trayanova NA
J Physiol; 2016 Dec; 594(23):6879-6891. PubMed ID: 26941055
[TBL] [Abstract][Full Text] [Related]
3. Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models.
Boyle PM; Murphy MJ; Karathanos TV; Zahid S; Blake RC; Trayanova NA
J Physiol; 2018 Jan; 596(2):181-196. PubMed ID: 29193078
[TBL] [Abstract][Full Text] [Related]
4. Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations.
Bruegmann T; Boyle PM; Vogt CC; Karathanos TV; Arevalo HJ; Fleischmann BK; Trayanova NA; Sasse P
J Clin Invest; 2016 Oct; 126(10):3894-3904. PubMed ID: 27617859
[TBL] [Abstract][Full Text] [Related]
5. Optogenetic Modulation of Arrhythmia Triggers: Proof-of-Concept from Computational Modeling.
Ochs AR; Boyle PM
Cell Mol Bioeng; 2023 Aug; 16(4):243-259. PubMed ID: 37810996
[TBL] [Abstract][Full Text] [Related]
6. Energy-Reduced Arrhythmia Termination Using Global Photostimulation in Optogenetic Murine Hearts.
Quiñonez Uribe RA; Luther S; Diaz-Maue L; Richter C
Front Physiol; 2018; 9():1651. PubMed ID: 30542292
[TBL] [Abstract][Full Text] [Related]
7. Optogenetic termination of atrial fibrillation in mice.
Bruegmann T; Beiert T; Vogt CC; Schrickel JW; Sasse P
Cardiovasc Res; 2018 Apr; 114(5):713-723. PubMed ID: 29293898
[TBL] [Abstract][Full Text] [Related]
8. Ultra-low power deep sustained optogenetic excitation of human ventricular cardiomyocytes with red-shifted opsins: a computational study.
Pyari G; Bansal H; Roy S
J Physiol; 2022 Nov; 600(21):4653-4676. PubMed ID: 36068951
[TBL] [Abstract][Full Text] [Related]
9. Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes.
Bingen BO; Engels MC; Schalij MJ; Jangsangthong W; Neshati Z; Feola I; Ypey DL; Askar SF; Panfilov AV; Pijnappels DA; de Vries AA
Cardiovasc Res; 2014 Oct; 104(1):194-205. PubMed ID: 25082848
[TBL] [Abstract][Full Text] [Related]
10. Optogenetic control of the guard cell membrane potential and stomatal movement by the light-gated anion channel
Huang S; Ding M; Roelfsema MRG; Dreyer I; Scherzer S; Al-Rasheid KAS; Gao S; Nagel G; Hedrich R; Konrad KR
Sci Adv; 2021 Jul; 7(28):. PubMed ID: 34244145
[TBL] [Abstract][Full Text] [Related]
11. Optogenetic termination of atrial tachyarrhythmias by brief pulsed light stimulation.
Nakao M; Watanabe M; Miquerol L; Natsui H; Koizumi T; Kadosaka T; Koya T; Hagiwara H; Kamada R; Temma T; de Vries AAF; Anzai T
J Mol Cell Cardiol; 2023 May; 178():9-21. PubMed ID: 36965700
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Electrophysiological Effects of Light-Activated Chloride Channels.
Kopton RA; Baillie JS; Rafferty SA; Moss R; Zgierski-Johnston CM; Prykhozhij SV; Stoyek MR; Smith FM; Kohl P; Quinn TA; Schneider-Warme F
Front Physiol; 2018; 9():1806. PubMed ID: 30618818
[TBL] [Abstract][Full Text] [Related]
13. Optogenetically mediated large volume suppression and synchronized excitation of human ventricular cardiomyocytes.
Pyari G; Bansal H; Roy S
Pflugers Arch; 2023 Dec; 475(12):1479-1503. PubMed ID: 37415050
[TBL] [Abstract][Full Text] [Related]
14. Optogenetic approaches for termination of ventricular tachyarrhythmias after myocardial infarction in rats in vivo.
Cheng Y; Li H; Wang L; Li J; Kang W; Rao P; Zhou F; Wang X; Huang C
J Biophotonics; 2020 Jul; 13(7):e202000003. PubMed ID: 32246523
[TBL] [Abstract][Full Text] [Related]
15. Optical capture and defibrillation in rats with monocrotaline-induced myocardial fibrosis 1 year after a single intravenous injection of adeno-associated virus channelrhodopsin-2.
Li J; Wang L; Luo J; Li H; Rao P; Cheng Y; Wang X; Huang C
Heart Rhythm; 2021 Jan; 18(1):109-117. PubMed ID: 32781160
[TBL] [Abstract][Full Text] [Related]
16. Systemic gene transfer enables optogenetic pacing of mouse hearts.
Vogt CC; Bruegmann T; Malan D; Ottersbach A; Roell W; Fleischmann BK; Sasse P
Cardiovasc Res; 2015 May; 106(2):338-43. PubMed ID: 25587047
[TBL] [Abstract][Full Text] [Related]
17. Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management.
Nyns ECA; Kip A; Bart CI; Plomp JJ; Zeppenfeld K; Schalij MJ; de Vries AAF; Pijnappels DA
Eur Heart J; 2017 Jul; 38(27):2132-2136. PubMed ID: 28011703
[TBL] [Abstract][Full Text] [Related]
18. Optogenetic Termination of Cardiac Arrhythmia: Mechanistic Enlightenment and Therapeutic Application?
Sasse P; Funken M; Beiert T; Bruegmann T
Front Physiol; 2019; 10():675. PubMed ID: 31244670
[TBL] [Abstract][Full Text] [Related]
19. Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach.
Karathanos TV; Boyle PM; Trayanova NA
Europace; 2014 Nov; 16 Suppl 4(Suppl 4):iv69-iv76. PubMed ID: 25362173
[TBL] [Abstract][Full Text] [Related]
20. Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 model.
Williams JC; Xu J; Lu Z; Klimas A; Chen X; Ambrosi CM; Cohen IS; Entcheva E
PLoS Comput Biol; 2013; 9(9):e1003220. PubMed ID: 24068903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
